Shares of Teleflex TFX fell 0.3% in pre-market trading after the company reported Q1 results.
Quarterly Results
Earnings per share were up 5.51% year over year to $2.87, which beat the estimate of $2.42.
Revenue of $633,925,000 up by 0.52% from the same period last year, which beat the estimate of $626,250,000.
Outlook
The upcoming fiscal year's EPS expected to be between $12.65 and $12.85.
The upcoming fiscal year's revenue expected to be between $2,803,385,000 and $2,835,097,500.
Details Of The Call
Date: Apr 29, 2021
Time: 08:00 AM
Price Action
Company's 52-week high was at $449.38
52-week low: $312.33
Price action over last quarter: Up 11.49%
Company Overview
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (26% of 2020 sales), interventional (15%), surgical (13%), anesthesia (12%), interventional urology (13%), original-equipment manufacturing (7%), and all other (14%). Geographic exposure for the business is primarily in the U.S., which accounts for 60% of revenue, with international markets making up the remainder.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.